NSETrading Window24 Jun 2026 · 24 Jun 2026, 04:02 pm
Trading Window
Sun Pharma Advanced Research Company Limited · SPARC
✦ AI Summary
Sun Pharma Advanced Research Company Limited has closed its trading window due to the declaration of unaudited financial results for the quarter ended June 30, 2026. The trading window will remain closed for 48 hours after the declaration.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sun Pharma Advanced Research Company Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
SPARC_24062026160243_IntimationClosureofTradingWindowQ1.pdf
View document text
SPARC/Sec/SE/2026-27/13 June 24, 2026
National Stock Exchange of India Ltd., BSE Limited,
Exchange Plaza, 5th Floor, Market Operations Dept.
Plot No. C/1, G Block, P. J. Towers,
Bandra Kurla Complex, Dalal Street,
Bandra (East), Mumbai – 400 051. Mumbai - 400 001.
Scrip Symbol: SPARC Scrip Code: 532872
Dear Sir/ Madam,
Sub: Intimation for Closure of Trading Window
This is to inform you that, pursuant to the SEBI (Prohibition of Insider Trading) Regulations,
2015, as amended and the Company’s Code of Conduct for Prevention of Insider Trading (“the
CoC”), the Trading Window for trading in shares of the Company shall remain closed with
effect from Wednesday, July 1, 2026 till 48 hours after the declaration of Unaudited Financial
Results of the Company for the quarter ended June 30, 2026.
The date of Board Meeting to approve the Unaudited Financial Results of the Company for the
quarter ended June 30, 2026 shall be intimated in due course.
This is for your information and record.
Thanking you,
For Sun Pharma Advanced Research Company Limited
Kajal Damania
Company Secretary and Compliance Officer